# CRITICAL BUG: products-by-approval-pathway Returns Wrong Drugs

**Status**: üî¥ CRITICAL - Skill returns incorrect results for therapeutic area filtering
**Date Discovered**: 2025-11-29
**Severity**: High - Affects all pathway queries with therapeutic area filters
**Impact**: Users get completely wrong drug lists (arthritis drugs instead of Alzheimer's drugs)

---

## Problem Summary

The `products-by-approval-pathway` skill v4.0 returns **completely incorrect drugs** when filtering by therapeutic area + pathway.

**Example Query**:
```
What Alzheimer's disease drugs received priority review designation from the FDA?
```

**Expected Result**:
- ARICEPT (donepezil)
- NAMENDA (memantine)
- LEQEMBI (lecanemab)
- ADUHELM (aducanumab)
- etc.

**Actual Result** (WRONG):
1. HUMIRA (adalimumab) - **Arthritis drug**
2. PREDNISONE - **Steroid**
3. REMICADE (infliximab) - **Autoimmune drug**
4. NEXIUM (esomeprazole) - **Acid reflux drug**
5. ASPIRIN - **Pain reliever**
6. BAYER - **Aspirin brand**
7. OMEPRAZOLE - **Acid reflux drug**
8. ASPICA (ASPIRIN) - **Pain reliever**

**None of these drugs are approved for Alzheimer's disease!**

---

## Root Cause

### Current Implementation (v4.0 Hybrid Adverse Events Discovery)

```python
# STEP 1: Query adverse events database
query = f"patient.drug.drugindication:{therapeutic_area}"

# Example for Alzheimer's:
# patient.drug.drugindication:Alzheimer
```

**What this actually finds**:
- Adverse event reports where the **patient has Alzheimer's disease** as a medical condition
- Includes ALL drugs those patients took (for ANY condition)
- ‚úÖ Drugs approved FOR Alzheimer's (ARICEPT, NAMENDA)
- ‚ùå Drugs for comorbid conditions (HUMIRA for arthritis, NEXIUM for GERD, etc.)

**The critical flaw**:
`patient.drug.drugindication` = **Patient's medical diagnoses**, NOT **Drug's approved indication**

### Why This Happens

Alzheimer's patients often have multiple conditions:
- Arthritis (HUMIRA, PREDNISONE)
- GERD/acid reflux (NEXIUM, OMEPRAZOLE)
- Cardiovascular disease (ASPIRIN)
- Autoimmune conditions (REMICADE)

The adverse events database captures **all drugs taken by Alzheimer's patients**, not just Alzheimer's treatments.

---

## Evidence from Execution Log

```bash
$ python3 .claude/skills/products-by-approval-pathway/scripts/get_products_by_approval_pathway.py \
    "priority_review" "Alzheimer's disease"

# Output:
‚úì Found 8 drugs with priority review designation

Drugs with Priority Review (8 found):
1. HUMIRA (172,744 adverse event reports)          # ‚ùå Arthritis drug
2. PREDNISONE (88,628 adverse event reports)       # ‚ùå Steroid
3. REMICADE (76,032 adverse event reports)         # ‚ùå Autoimmune drug
4. NEXIUM (74,923 adverse event reports)           # ‚ùå Acid reflux drug
5. ASPIRIN (70,945 adverse event reports)          # ‚ùå Pain reliever
6. BAYER (70,909 adverse event reports)            # ‚ùå Aspirin brand
7. OMEPRAZOLE (70,893 adverse event reports)       # ‚ùå Acid reflux drug
8. ASPICA (ASPIRIN) (70,874 adverse event reports) # ‚ùå Pain reliever
```

**Reality Check**: HUMIRA is indicated for rheumatoid arthritis, Crohn's disease, and psoriasis. It has ZERO Alzheimer's indication.

---

## Impact Assessment

### Queries Affected
- ‚úÖ **Works correctly**: "All orphan drugs" (no therapeutic area filter)
- ‚úÖ **Works correctly**: "All priority review drugs" (no therapeutic area filter)
- ‚ùå **BROKEN**: "Alzheimer's drugs with priority review" (therapeutic area + pathway)
- ‚ùå **BROKEN**: "Diabetes drugs with orphan designation" (therapeutic area + pathway)
- ‚ùå **BROKEN**: Any pathway query WITH therapeutic area filtering

### User Trust Impact
- Users asking for Alzheimer's drugs get arthritis drugs
- Results look plausible (FDA-approved drugs with correct pathway)
- **Silent failure**: No error message, just wrong data
- High adverse event counts make wrong drugs look "important"

### Scope
- Affects **all 89 skills** that might use this as a reference pattern
- Semantic matcher now routes pathway queries to this broken skill (score: 23)
- Marked as `is_generic: true`, so it will be reused for all pathway queries

---

## Correct Implementation Approaches

### Option 1: Drug Label Search (Recommended)

Query FDA drug labels for drugs approved for the indication:

```python
# STEP 1: Find drugs with Alzheimer's indication in drug labels
lookup_drug(
    search_term="indications_and_usage:Alzheimer",
    search_type="label",
    count="openfda.brand_name.exact",
    limit=100
)

# STEP 2: For each drug, check pathway designation
lookup_drug(
    search_term=f"openfda.brand_name.exact:{brand_name}",
    search_type="label",
    fields_for_label="submissions"
)
# Check: submissions.submission_property_type.code == "Orphan" / "PRIORITY"
```

**Pros**:
- ‚úÖ Returns drugs actually approved FOR the indication
- ‚úÖ Uses official FDA drug label data
- ‚úÖ Accurate therapeutic area filtering

**Cons**:
- ‚ö†Ô∏è More complex query pattern
- ‚ö†Ô∏è May miss some drugs if label text varies

### Option 2: Reverse Query (All Pathway Drugs ‚Üí Filter by Indication)

```python
# STEP 1: Get all drugs with priority review designation
lookup_drug(
    search_term="submissions.submission_property_type.code:PRIORITY",
    search_type="label",
    count="openfda.brand_name.exact",
    limit=100
)

# STEP 2: For each drug, check if indicated for Alzheimer's
lookup_drug(
    search_term=f"openfda.brand_name.exact:{brand_name} AND indications_and_usage:Alzheimer",
    search_type="label"
)
```

**Pros**:
- ‚úÖ Guaranteed to find all pathway drugs
- ‚úÖ Simple pathway filtering

**Cons**:
- ‚ö†Ô∏è Two-pass query (slower)
- ‚ö†Ô∏è Limited to 100 pathway drugs

### Option 3: Remove Therapeutic Area Support

Mark the skill as NOT supporting therapeutic area filtering:

```python
def get_products_by_approval_pathway(pathway: str, therapeutic_area: Optional[str] = None):
    if therapeutic_area:
        raise ValueError(
            "Therapeutic area filtering not supported. "
            "Use this skill to find ALL drugs with the pathway, "
            "then manually filter by indication."
        )
```

**Pros**:
- ‚úÖ Simple fix
- ‚úÖ Prevents wrong results
- ‚úÖ Forces user to use correct tool

**Cons**:
- ‚ùå Loses functionality
- ‚ùå User frustration

---

## Recommended Fix

**Approach**: Option 1 (Drug Label Search)

**Implementation**:
1. Create new skill: `get_drugs_by_indication_and_pathway`
2. Use drug label search with indication filtering
3. Cross-reference with submission metadata for pathway
4. Mark `products-by-approval-pathway` as deprecated or limit to pathway-only queries
5. Update semantic matcher to prefer the new skill for indication+pathway queries

**New Function Signature**:
```python
def get_drugs_by_indication_and_pathway(
    indication: str,
    pathway: str,  # priority_review | orphan | standard_review
    search_type: str = "exact"  # exact | contains
) -> dict:
    """
    Find FDA-approved drugs by indication AND regulatory pathway.

    Uses drug label search for accurate indication filtering.

    Args:
        indication: Drug indication (e.g., "Alzheimer", "diabetes")
        pathway: Regulatory pathway designation
        search_type: How to match indication (exact or contains)

    Returns:
        dict with drugs, count, and detailed metadata
    """
```

---

## Testing Plan

### Test Cases

```python
# Test 1: Alzheimer's + Priority Review
result = get_drugs_by_indication_and_pathway("Alzheimer", "priority_review")
# Expected: ARICEPT, NAMENDA, LEQEMBI, ADUHELM
# NOT: HUMIRA, NEXIUM, ASPIRIN

# Test 2: Diabetes + Orphan Designation
result = get_drugs_by_indication_and_pathway("diabetes", "orphan")
# Expected: Drugs specifically approved for diabetes with orphan designation
# NOT: All drugs taken by diabetic patients

# Test 3: Cancer + Priority Review
result = get_drugs_by_indication_and_pathway("cancer", "priority_review")
# Expected: Cancer drugs with priority review
# Verify against known cancer drugs (KEYTRUDA, OPDIVO, etc.)
```

### Validation Criteria

For each result:
1. ‚úÖ Drug's FDA label mentions the queried indication
2. ‚úÖ Drug's submission metadata shows the queried pathway
3. ‚ùå No drugs for unrelated conditions
4. ‚ùå No generic drugs taken by patients with the condition

---

## Immediate Actions Required

1. **Mark skill as broken** in index.json:
   ```json
   {
     "name": "get_products_by_approval_pathway",
     "health_status": "broken",
     "health_issues": [
       "Therapeutic area filtering returns wrong drugs (comorbid conditions)",
       "Uses patient diagnosis instead of drug indication"
     ]
   }
   ```

2. **Remove `is_generic: true` flag** to prevent automatic reuse

3. **Update trigger keywords** to remove therapeutic area combinations:
   ```json
   "trigger_keywords": [
     "all priority review drugs",
     "all orphan drugs",
     "all standard review"
     // Remove: "alzheimer priority review", etc.
   ]
   ```

4. **Create warning in SKILL.md**:
   ```markdown
   ## ‚ö†Ô∏è CRITICAL LIMITATION

   **DO NOT use this skill with therapeutic area filtering!**

   The adverse events method finds drugs taken by patients WITH the condition,
   not drugs approved FOR the condition.

   ‚ùå WRONG: get_products_by_approval_pathway("priority_review", "Alzheimer")
   ‚Üí Returns arthritis drugs, acid reflux drugs, etc.

   ‚úÖ CORRECT: Use for pathway-only queries
   ‚Üí get_products_by_approval_pathway("priority_review", None)
   ```

5. **Invoke pharma-search-specialist** to create correct skill for Alzheimer's priority review query

---

## Long-Term Solution

**Goal**: Create robust indication + pathway filtering skill

**Requirements**:
- Accurate drug indication matching (from FDA labels)
- Pathway designation cross-reference (from submission metadata)
- Support for exact and fuzzy indication matching
- Proper error handling when no drugs found
- Clear documentation of method limitations

**Timeline**:
- Immediate: Mark current skill as broken, add warnings
- Short-term (next session): Create correct implementation
- Long-term: Deprecate v4.0 hybrid method for therapeutic area queries

---

## Related Issues

- Semantic matcher fix (completed 2025-11-29) - needs to be aware of skill health status
- Strategy system should check health status before REUSE
- Index needs health status tracking and automatic warnings

---

## References

- FDA Adverse Events API: https://open.fda.gov/apis/drug/event/
- FDA Drug Labels API: https://open.fda.gov/apis/drug/label/
- Skill location: `.claude/skills/products-by-approval-pathway/`
- Discovery log: User session 2025-11-29 ~00:48 AM

---

## Notes

This bug demonstrates why **data source validation is critical**. The v4.0 "breakthrough" method looked promising (100% coverage!) but had a fundamental flaw in understanding what the data actually represents.

**Key lesson**: Patient medical history ‚â† Drug's approved indication

The adverse events database is excellent for finding prescribed drugs, but terrible for finding drugs approved for specific indications.
